GDF-16 Antibodies

Santa Cruz Biotechnology features a diverse variety of GDF-16 monoclonal antibodies for research focused on understanding Growth Differentiation Factor 16. GDF-16 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).GDF-16, also known as macrophage inhibitory cytokine 1 (MIC-1), is a member of the transforming growth factor-beta (TGF-β) superfamily and plays a crucial role in regulating inflammation, apoptosis, and cellular differentiation. GDF-16 expression is often associated with various physiological and pathological processes, including cancer progression and metabolic disorders. Understanding GDF-16 function is essential for elucidating its potential as a biomarker and therapeutic target in various diseases. Research has shown that GDF-16 signaling pathways influence cell growth and development across multiple tissue types. Recent studies have highlighted GDF-16's involvement in immune response regulation and tissue repair mechanisms. Ongoing investigations continue to reveal new insights about GDF-16's role in disease progression and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of GDF-16 and its impact on human health.